We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Psychedelics – News and Features

Clouds in rainbow colours in the sky.

LSD Tied to Worse Mental Health After Job Loss

Lifetime LSD use is associated with a higher likelihood of severe psychological distress after losing one’s job. The new work used data from the 2008-2019 National Survey on Drug Use and Health on the United States civilian, non-institutionalized population.
A doctor writing on a clipboard next to a 3D model of a human brain and two orange pill bottles.

New Rules for Psychedelic Therapy Programs

Oregon is first in the nation to provide state-regulated access to magic mushrooms; study is first to identify measures for high-quality services.
A person laying down.
Industry Insight

What FDA Approval of MDMA Could Mean for the Future of Psychedelic Therapy

To learn more about the FDA's pending decision on MDMA-assisted therapy for PTSD, Technology Networks interviewed Dr. Sam Clark, CEO of Terran Biosciences, who leads one of the industry’s largest psychedelic development programs.
Two halves of a drug capsule split, with a drug molecule in the middle.

Nanodroplets and Ultrasound Beams Trigger Drug Delivery at Exactly the Right Spot

In preclinical experiments, researchers optimized a targeted drug delivery method where nanocarriers release their cargo at exactly the desired location.
Three red and white mushroom.

Interest in Potentially Harmful “Magic Mushroom” May Endanger Public Health

Interest in a potentially harmful "magic mushroom" is skyrocketing. Amanita muscaria is being marketed as having similar health benefits to psilocybin, despite being completely different.
Abstract psychedelic image of a person and clouds.

First Patient Dosed in Study To Unravel “Mystical Experiences” of Psychedelic Derived From Toad Skin

The first participant in a new psychedelic study has received a dose of a synthetic formulation of 5-MeO-DMT. The study is set to evaluate its neurophysiological effects on the human brain and perceived “mystical experiences.”
A man's hand with pills spilled out of the container.

Framework Offers New Understanding on How Antidepressants Work in MDD

Researchers at the University of Colorado Anschutz Medical Campus have established a new framework for understanding how classic antidepressants work in treating major depressive disorder (MDD).

MDMA Therapy for PTSD Receives “No” Vote From FDA Advisory Committee

A key advisory panel to the US FDA has voted that midomafetamine (MDMA) is not effective nor risk-free for treating PTSD.
A hand holds a small mushroom.

Psilocybin Causes Feelings of “Oceanic Boundlessness”

A new study shows how psilocybin initiates hyperconnectivity in the brain, causing feelings of "oceanic boundlessness", providing insights into its potential use to treat psychiatric disorders.
A purple human brain.

Ketamine’s Molecular Action on Brain Network Function

New research addresses a gap in understanding how ketamine’s impact on individual neurons leads to pervasive and profound changes in brain network function.